HHMI - Howard Hughes Medical Institute

HHMI scientists have joined their colleagues around the world in working to understand and slow the spread of COVID-19. They’re developing diagnostic testing, understanding the virus’s basic biology, modeling the epidemiology, and developing potential therapies or vaccines.

An ion channel called TRPC5 acts as a molecular cold sensor in teeth and could serve as a new drug target for treating toothaches.

Intensive training in young mice staves off symptoms of a rare neurological disorder that afflicts young girls. The discovery may spark new ideas for treatments in humans.

Scientists have identified proteins in aphid saliva that can alter plant development. These proteins drive abnormal growths called galls, which give insects a protected place to feed and reproduce.

New cryo-electron microscopy images suggest archaeal microbes pack their chromatin into tight coils that can spring open, forming unexpected contortions.

HHMI announces the selection of 21 exceptional early career scientists as 2020 Hanna Gray Fellows to support diversity in biomedical research. The 2022 Hanna H. Gray Fellows Program competition will open later this year.

People taking cholesterol-lowering drugs may fare better than others if they catch the novel coronavirus. A new study hints at why: the virus relies on the fatty molecule to get past the cell’s protective membrane.

Julius, a professor at the University of California, San Francisco, will join HHMI’s Board of Trustees.

Lavizzo-Mourey, University of Pennsylvania professor and former president and CEO of the Robert Wood Johnson Foundation, will join HHMI’s Board of Trustees.